Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: Report on 453 cases between 2003 and 2005.
about
Population-based epidemiology and microbiology of community-onset bloodstream infectionsCanadian clinical practice guidelines for invasive candidiasis in adults.Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Analysis of the clonality of Candida tropicalis strains from a general hospital in Beijing using multilocus sequence typing.Multilocus microsatellite markers for molecular typing of Candida tropicalis isolates.Epidemiology of candidemia in Latin America: a laboratory-based survey.Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia.Comparison of dimethyl sulfoxide and water as solvents for echinocandin susceptibility testing by the EUCAST methodology.Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.A single-centre 10-year experience with Candida bloodstream infections.The Prospective Antifungal Therapy Alliance(®) registry: A two-centre Canadian experience.Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in BrazilTen-year review of candidemia in a Canadian tertiary care centre: Predominance of non-albicans Candida species.Utility of the germ tube test for direct identification of Candida albicans from positive blood culture bottles.Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.The efficacy of gaseous ozone against different forms of Candida albicans.
P2860
Q27013639-A0BCDB5F-188E-48FF-BE0A-EF57A8B29132Q34237335-61972CD4-D38B-4591-948D-0B3ED7FFAB48Q34372192-ABB7D102-7518-4552-9BEE-D9F7AF83BD98Q34477272-1D69B906-0B82-4702-8C47-5C600EB27139Q34584323-62046094-F549-46AB-9131-F02CB942EB3EQ34635088-DE1CDE92-9BEE-47D8-8131-103B32EE96F7Q35192301-D731F278-8550-4718-B5E6-5F1548031329Q36118827-252778C8-3DA9-4AC0-A5E1-EA6AAE1439EAQ36933437-EB4F7352-C495-4756-B41A-BFA3514B286EQ37252122-CBB2E97E-1E08-4B60-9CFB-D70E0E9A58F1Q37632406-641EF30C-8419-4814-A30C-1CDFA841F750Q37734169-CF718977-3960-47AB-91CA-9C0CB5000646Q38178257-88CDDA9E-EE38-4182-80EF-03A745FC5C9BQ43193447-DE537577-68A4-47FD-80B7-C7AF42A7F6EBQ47646997-6C8D9690-9C31-423C-975C-2A63C106F9EDQ47707544-1C114B6D-7C72-41E7-AC42-9E4FD479008F
P2860
Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: Report on 453 cases between 2003 and 2005.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology and antifungal su ...... 3 cases between 2003 and 2005.
@en
Epidemiology and antifungal su ...... 3 cases between 2003 and 2005.
@nl
type
label
Epidemiology and antifungal su ...... 3 cases between 2003 and 2005.
@en
Epidemiology and antifungal su ...... 3 cases between 2003 and 2005.
@nl
prefLabel
Epidemiology and antifungal su ...... 3 cases between 2003 and 2005.
@en
Epidemiology and antifungal su ...... 3 cases between 2003 and 2005.
@nl
P2093
P2860
P356
P1476
Epidemiology and antifungal su ...... 3 cases between 2003 and 2005.
@en
P2093
Anne-Marie Bourgault
Claude Lemieux
Guy St-Germain
Michael Libman
Michel Laverdière
Pierre René
René Pelletier
P2860
P356
10.1155/2008/634046
P407
P577
2008-01-01T00:00:00Z